Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

EHA 2015 | Adaptive licensing: A new approach for authorizing medicines

Stephen O’Brien • 12 Jun 2015
EHA 2015
General

At the 20th Congress of the European Hematology Association (EHA), Stephen O’Brien, BSc (Hons), PhD, MBChB, FRCP, FRCPath, of the University of Newcastle, Newcastle upon Tyne, UK, explains the process of adaptive licensing of new medicines, which aims to improve timely access for patients to new medicines.

More from Stephen O’Brien

2:03
Engaging patients in clinical research
Stephen O’Brien • 12 Jun 2015
1:38
Outlook for the management of chronic myeloid leukemia
Stephen O’Brien • 12 Jun 2015
2:29
SPIRIT2 trial on dasatinib for AML - safety and side effect management
Stephen O’Brien • 18 Apr 2016

Related Videos

4:07
Pooled fecal allogeneic microbiotherapy to treat refractory gastrointestinal acute GvHD
Florent Malard • 11 Apr 2024
5:23
Current and emerging treatment approaches for steroid-refractory acute & chronic GvHD
Mohamad Mohty • 17 Apr 2024
2:00
HHV-6 reactivation after haploidentical transplantation with PTCy & ATG: incidence and risk factors
Rémy Duléry • 15 Apr 2024
1:41
The consequences of regulatory changes on access to devices and reagents needed for graft processing
Christian Chabannon • 16 Apr 2024
The content of VJHemOnc is intended for healthcare professionals